find your perfect postgrad program
Search our Database of 30,000 Courses
Feb. 11, 2026
A breakthrough in hearing loss research at UCL
Researchers at UCL Ear Institute and UCLH have completed the world’s first clinical trial of a drug designed to help the ear repair itself. This marks a major step forward, as people with permanent hearing loss currently rely on hearing aids, which amplify sound but do not address the underlying damage.
What causes most hearing loss?
Inside the inner ear are tiny sensory “hair cells” that enable us to hear. Ageing and long-term noise exposure can damage or destroy these cells, and, unlike in some animals, humans cannot naturally regenerate them. As a result, hearing loss usually worsens over time.
What does the new drug aim to do?
The experimental drug, LY3056480, is designed to stimulate the regeneration of these damaged sensory cells. If effective, it could help restore some natural hearing – something currently impossible with existing treatments.
How did the trial work?
The study was part of an international collaboration involving teams in the UK, Germany and Greece. Participants aged 18 to 80 with mild to moderate hearing loss took part. Each received three small injections of the drug through the eardrum into the middle ear.
Before and after treatment, researchers carried out hearing tests, measuring:
- The quietest sounds participants could detect
- How well they understood speech in noisy environments
What did the researchers find?
The trial showed the drug is safe, which is a crucial first step. While it did not restore hearing across the whole group, there were encouraging signs: around 45% of participants could detect sounds at least 10 decibels quieter than before treatment. This did not meet the trial’s strict success criteria, but it suggests the drug may have had an effect inside the inner ear and could be promising for future development.
Why is this exciting for the future?
Hearing loss is the most common sensory impairment worldwide, and current treatments do not repair the core problem: the loss of sensory hair cells. A therapy that helps these cells regenerate would represent a major shift in hearing care.
This trial shows that regenerative approaches – once thought impossible – may one day offer real solutions. The insights gained will help researchers design future studies and advance the field of regenerative hearing medicine.
Read the full UCL news article.
Looking for funding for postgraduate studies? Check out the exclusive bursaries on offer from Postgrad Solutions.
Content added on 11th February 2026.
Most Popular News
-
University of Aberdeen announces £8,000 Global Scholarship for international postgrads
March 26, 2026The University of Aberdeen has announced the continuation of its Aberdeen Global Scholarship, offering an £8,000 tuition fee reduction to self‑funded international students beginning postgraduate study in the 2026/27 academic year.
-
Kent Business School Professional Practice and Placement masters include guaranteed internships
March 26, 2026Kent Business School is offering new masters degrees that can be studied over two years and include a 44-week Industry Placement or a new Professional Practice option with an eight-week virtual internship.
-
Why study for a Masters in Public Health at the University of Essex Online?
March 25, 2026Whether you’re looking to build a successful career or step towards progression in public health, epidemiology and health research areas, the University of Essex Online’s Master of Public Health (MPH) is designed to support your professional development.
-
Essex Online has MSc Artificial Intelligence with April start date
March 16, 2026The University of Essex Online’s MSc in Artificial Intelligence is designed to provide a solid understanding of the theories and methodologies of artificial intelligence, together with ways to apply these new skills.
